Clinical Trial Update: Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating whether synbiotics and prebiotics can lessen chemotherapy-associated cognitive decline (chemobrain) in first-line breast cancer p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Cognitive Impairment

Drugs mentioned

• Synbiotics and Prebiotics supplementation

Snippet

Sponsor: Instituto Jalisciense de Cancerologia | Conditions: Chemobrain, Breast Cancer | NA | Status: ENROLLING_BY_INVITATION